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The Assault on Managed Care: Vicarious Liability, Class Actions and
the Patient’s Bill of Rights
by
Richard A. Epstein* and Alan O. Sykes**
The purpose of this paper is to offer an evaluation of recent legal
initiatives targeting managed care organizations (MCOs) for their allegedly
deficient supply of health care to their consumers. These MCOs--which tend to
inject the provider of health care coverage into decisions over the type and
amount of health care services provided--have grown in number, size and
market penetration since the 1980s. Speaking in the round, the best explanation
for their success is that they have responded to the serious shortfalls in the earlier
private regimes for delivery of health care insurance, namely, the use of
indemnity insurance contracts that required the insurer to reimburse the
designated health care provider on a fee-for-service basis. That arrangement
created strong incentives for the formation of a physician/patient alliance to
increase the level of health care consumed above and beyond levels that would
be regarded as cost-justified in the absence of a third party provider. It is far
easier to demand services, which at the time of delivery are paid for by others,
1
rather than by one’s self.
The rise of the MCO responded to these structural weaknesses of the
indemnity insurance model. The efficiency gains came not from substituting a
flawless alternative to fee-for-service, but from substituting smaller contracting
problems for larger ones. And the market penetration of the MCO suggests that
its organizational structure is better tailored to the control of risk, to the
introduction of new technology, and to the management of a patient base than
the prior alternatives.
Yet so long as MCOs assume the care of millions of people, the law of
large numbers warns us to expect legal disputes between patients and their
MCO. Medical services are difficult to monitor and on specified occasions may
easily go astray. Bad outcomes could be attributable to hopeless medical
situations, to callous indifference of health care providers, or to a simple want of
*
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For a basic account of the problem, see Patricia Danzon, Tort Liability: A Minefield for
Managed Care? 26 J. Legal Stud. 491 (1997); Richard A. Epstein, Managed Care Under Siege, 24 J.
Medicine & Phil. 434 (1999).
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ordinary care under the circumstances. In this environment, the greater control
over patient care exerted by MCOs has invited greater assaults on the activities
of MCOs. The modern attack on them takes place along two key dimensions.
First, in the most conspicuous recent developments, injured plaintiffs have
to come rely on theories of vicarious liability and negligence to reach not only the
hospital or physicians group that employs the individual physician, but also the
MCO responsible for the selection, management and payment for medical
services delivered by physicians and hospital groups. These individual lawsuits
brought against these MCOs fall into two broad categories. The first category
involves claims for personal injuries that arise out of the delivery of medical
services. In these suits, the plaintiff alleges that his condition was brought about
by, or worsened by, the MCO’s decision, often made on cost grounds, to deny or
limit some treatment that the treating physician had recommended for the
patient. Sometimes, these suits allege negligence on the part of both the
individual physician and the MCO that oversaw its action. At other times, the
allegations of negligence are directed solely to the physician in question. The
MCO is joined as a defendant either on the ground that it held out the physician
as its employee or exerted sufficient control over his activities so as to treat the
physician not an independent contractor, but as an employee.2 These suits are
brought under state law, where the plaintiffs assert that the defendants are not
entitled to refuge under the so-called ERISA preemption doctrine that otherwise
prevents medical malpractice actions from being brought against the
administrators of medical health plans.
Side-by-side with the expanded set of malpractice and coverage actions
against MCOs is a fresh onslaught of class actions. Typically, these suits do not
allege any medical malpractice toward class members. Rather, they seek to
attack as a business and financial matter the entire range of practices that MCOs
institute in order to control the cost of care in medical cases. As is the habit
today, these suits are not only based on common law theories of breach of
contract, fraud and nondisclosure, but they also escalate the struggle by
including counts that might allow punitive damages and attorney’s fees—counts
that allege racketeering under both RICO (the Racketeer Influenced and Corrupt
3
4
Organizations and ERISA (the Employee Retirement and Income Security Act) .
The filing of these lawsuits is often accompanied by an extensive publicity and
public relations campaign, much of which is directed to the stock analysts. As
was the case with the tobacco litigation, the purpose of these suits may be not so
2

For a recent illustration involving both theories, see Petrovich v. Share Health Plan. Inc.
719 N.E.2d 756 (Ill. 1999).
3
18 U.S.C. §§1961-68.
4
29 U.S.C. §1001 et. seq.
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much to win a jury verdict, but to inflict sufficient interim reputational damages
so as to create the climate for an industry-wide settlement that both alters
standard medical practice, and places a tidy sum of wealth in the hands of the
plaintiffs’ lawyers who initiated the suit.
This paper intends to evaluate these two legal movements. In order to do
so it is necessary to state the benchmark against which this evaluation will take
place. Here our basic position is that most of the maneuvers involved in these
attacks on managed care are inconsistent with the basic legal theories that define
(a) the contract/tort boundary, (b) the principles of vicarious liability and (c) the
proper role of class action as a procedural device to amalgamate individual
claims that would otherwise not be brought. The first part of that analysis begins
with the proposition that the undisputed place for the law of torts is in the
prevention of harms that one person (or organization) inflicts on strangers—that
is those persons with whom it has no ongoing business relationships, or any
convenient opportunity of establishing one prior to some harmful encounter.
Typical illustrations of this relationship is the hunter whose stray bullet kills or
injures an innocent bystander, the railroad whose sparks destroy a nearby
farmhouse, or the factory whose pollution causes widespread physical damage
to streams and the fish that swim in them. In these cases, the unregulated actor
is able to internalize all of the gain, but is forced to bear only part of the loss
associated with its activity. The upshot is that these actors will on average
engage in too much risky activity. Only if forced to bear the losses inflicted on
others will they monitor activities that they undertake and the care used in
undertaking them.
The principles of tort law have another component that deals with the role
of the plaintiff. In the ordinary stranger case, the plaintiff’s own action
sometimes helps to bring about the harm, at which point a defense of
contributory negligence could allow the defendant to bar or reduce the recovery
in question. In non-stranger cases, the potential plaintiff, having a prior
relationship with the potential defendant, may wish to anticipate the possibility
of harm and enter into some kind of advance agreement that allocates the risk of
loss before it occurs. To be useful, such agreements must have the capacity to
override the legal default rules that would otherwise apply. But the dominant
5
legal position today often tends to disfavor or disallow these deviations.
On our view of the world, however, the entire area of medical services
should be understood as involving a network of contracts and should not

5

See, e.g., Tunkl v. Regents of University of California, 383 P.2d 441 (Cal. 1963). The
literature on this issue is enormous. See generally, Symposium, Medical Malpractice: Can the
Private Sector Find Relief?, 49 Law & Contemp. Problems, 1 (1986).
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unthinkingly invoke the norms of tort law in stranger cases. The key inquiry is
whether something in the process of contract formation, or in the structure of the
health care industry, precludes the use of the standard market principle that
binds parties, regardless of personal status or social station, by agreement. Our
position cuts against the received wisdom, and much of the difficulty that we
have with the recent attacks on managed care stems from the refusal of courts
and legislators to allow contract to dominate tort rather than the other way
around.
Part I of this paper looks at the individual lawsuits against MCOs with
reference to the principles of vicarious liability and to the question of what, if
anything, displaces the primacy of contract in this area. Part II then extends the
analysis to the special wrinkles introduced by class actions.
I. The Liability of Managed Care Organizations
In this section, we lay out the existing law governing the liability MCOs,
and examine certain prominent proposals to expand its scope. We then discuss
the wisdom of the current law and the proposed alternatives for policing
managed care.
A. The Legal Landscape
Although individual arrangements may vary, MCOs usually contract with
employers and occasionally individuals to provide a bundle of health care
services for a predetermined fee. In some instances, the MCOs employ salaried
health care professionals to deliver these services. In other instances, health care
services are delivered through a network of independent contractors (such as the
typical preferred provider network).7
Two principal types of disputes arise between MCOs and the patients
covered by them. First, patients may complain that their physicians have made
errors in their treatment -- conventional claims of malpractice. Second, patients
may complain that their MCO has denied coverage that it is contractually bound
to provide. Although complaints about malpractice and improper denial of
coverage are conceptually distinct, in practice they sometimes blend together.
The refusal of an MCO to provide an expensive treatment that might have
6

For the early defense of this position, see Richard A. Epstein, Medical Malpractice: The Case for
Contract, [1976] Am. Bar Found. J. 87; see also, Patricia Danzon, Medical Malpractice: Theory,
Evidence, and Public Policy (1985); Clark C. Havighurst, Health Care Choices: Private Contracts
as Instruments of Health Reform (1995).
7
See, e.g., Petrovich v. Share Health Plan of Illinois, Inc., 719 N.E.2d 756, 763-64 (Ill. 1999)
(citing 215 Ill. Comp. Stat. 125/1-2(7) (LEXIS through Public Act 91-712) (defining “Independent
Practice Association” Health Maintenance Organizations (HMOs) as “financing entities that
arrange and pay for health care by contracting with independent medical groups and
practitioners.”)).
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improved the patient’s outcome, for example, may be characterized as a failure
of its physicians to live up to the industry standard of care (malpractice), or as an
erroneous refusal to provide proper coverage, perhaps on grounds that the
8
treatment was not “medically necessary” or was “experimental.” The legal
remedies available to patients in these disputes involve a complex amalgam of
state and federal law.
1. MCO Liability for Physician Malpractice
Lawsuits against physicians alleging medical malpractice are governed
by state tort law. The plaintiff must show that the physician was “negligent”—
usually, a failure of the physician to provide the treatment that a reasonable
practitioner with comparable medical training would have provided under the
9
circumstances. Successful plaintiffs can recover the standard array of damages
in personal injury cases, including medical expenses, lost wages, damages for
loss of consortium, damages for pain and suffering, and statutory wrongful
death damages. In egregious cases, punitive damages may be recovered,
10
although punitive awards are rare in medical malpractice actions.
If a physician who is found liable for medical malpractice is a salaried
employee of a hospital or medical center, the doctrine of respondeat superior
allows the plaintiff to obtain a judgment against the employer as well. Such
liability is often termed “vicarious liability.” Even if the physician is an
independent contractor, the associated hospital or medical center may be
vicariously liable for the physician if an argument can be made that the hospital
11
The
misled the public into believing that the physician was its employee.
8

See, e.g., Pegram v. Herdrich, 120 S. Ct. 2143, 2155 (2000) (noting that all the petitioner’s
allegations target medical necessity determinations).
9
Minnesota’s Jury Instruction Guide provides a typical example of this standard: “a doctor
must use that degree of skill and learning which is normally possessed and used by doctors in
good standing in a similar practice in similar communities and under like circumstances.” 4
Minnesota District Judges Association Committee on Jury Instruction Guides, Minnesota Practice
§ 425 G-S (2d ed. 1974), approved in Kalsbeck v. Westview Clinic, P.A., 375 N.W.2d 861, 868
(Minn. App. 1985).
10
In a survey of Cook County, for example, there was only one punitive damage award for
medical malpractice from 1960 – 1984. See Michael J. Saks, Do We Really Know Anything About
the Behavior of the Tort Litigation System—And Why Not?, 140 U. Pa. L. Rev. 1147, 1256 (1992)
(citing Mark A. Peterson, et al., Punitive Damages, Empirical Findings 13 (1987)). See also,
Theodore Eisenberg, et al., The Predictability of Punitive Damages, 26 J. Legal Stud. 623, 637
(1997): “[P]unitive damages are most frequently awarded in the areas of law where breach of a
legal duty suggests intentional or morally flawed behavior. In traditional tort areas where
morally culpable conduct is not necessarily involved, including automobile, medical malpractice,
and products liability cases, punitive damages awards are very rare.”
11
Hardy v. Brantley, 471 So. 2d 358, 371 (Miss. 1985). See also, Petrovich, 719 N.E.2d at 765
(applying the apparent authority standard announced in Gilbert v. Sycamore Mun. Hospital, 622
N.E.2d 788 (Ill. 1993) to the HMO context). For a similar view, see, Restatement (Second) of
Agency §267: “One who represents that another is his servant or other agent and thereby causes a
third person justifiably to rely upon the care of skill of such apparent agent is subject to liability to

MCO E/S

December 12, 2000

5

imposition of liability on this basis occurs pursuant to the “apparent authority”
or “ostensible agency” doctrine. Similarly, even if the physician and the
affiliated hospital or medical center treat the physician as an independent
contractor for internal purposes, vicarious liability may be imposed if the
hospital or medical center exercises a high degree of control over the physician’s
medical decisions. Liability on this basis arises because of “implied agency.”12
The liability of an MCO for malpractice by an affiliated physician is more
complicated because of the Employee Retirement Income Security Act of 1974
(ERISA). ERISA to a degree displaces (“preempts”) state law affecting employee
benefit plans in the private sector (it does not apply to employee benefit plans for
13
government employees). Many MCOs, of course, provide health care services
through employer-sponsored group insurance plans, and are thus covered by
ERISA preemption. The scope of this preemption, however, is not entirely clear.
Specifically, ERISA preempts state laws that “relate to” a covered
employee benefit plan.14 The precise meaning of this phrase has been a subject of
extensive litigation and a number of Supreme Court decisions. Following the
15
Court’s decision in Pilot Life, conventional wisdom had it that ERISA preempted
state law in virtually any lawsuit relating to health care coverage or quality
under a covered plan. Some courts thus held that MCOs could not be held liable
for medical malpractice under state law even if standard agency principles
would otherwise impose liability.16 But subsequent Supreme Court decisions
limited the scope of preemption,17 and a number of lower federal and state courts
then concluded that MCOs can be held liable for malpractice by their actual,
18
implied or ostensible agent physicians.

the third person for harm caused by the lack of care or skill of the one appearing to be a servant
or other agent as if he were such.”
12
See, e.g., Petrovich, supra.
13
29 U.S.C. §§1002(32), 1003(b)(1). See, e.g, McEvoy v. Group Health Cooperative of Eau
Claire, 570 N.W.2d 397, 406 n.6 (Wis. 1997) (noting that ERISA preemption does not apply to
benefits plans offered by government employers).
14
29 U.S.C. §1144(a).
15
Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41 (1987).
16
See, e.g., Elsesser v. Hospital of the Phila. College of Osteopathic Medicine, 802 F. Supp.
1286 (E.D. Pa. 1992) (finding that ERISA preempted direct liability claim)
17
New York State Conference of Blue Cross & Blue Shield Plans v. Travelers Ins. Co., 514
U.S. 645, 654-55 (1995) (finding in the field of health care that there is no ERISA preemption
without clear manifestation of congressional purpose). See also, De Buono v. NYSA-ILA Med. &
Clinical Servs. Fund, 520 U.S. 806 (1997) (relying on Travelers Ins., and declaring a state statute
imposing a gross receipt tax on medical centers is not pre-empted by ERISA).
18
See, Dukes v. U.S. Healthcare, Inc., 57 F.3d 350 (3d Cir 1995) (finding that ERISA did not
preempt ostensible agency claims). See also, Petrovich, 719 N.E.2d at 775 (“An HMO may be
held vicariously liable for the negligence of its independent-contractor physicians under both the
doctrines of apparent authority and implied authority.”).
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The emergent distinction in the law of ERISA preemption is between
claims regarding a denial of coverage (preempted because they “relate to” the
administration of the benefit plan), and claims regarding the quality of care
provided by the plan (not preempted because they involve medical decisions
rather than plan administration decisions). The utility of this distinction may be
questioned for the reason given above -- malpractice claims and coverage claims
are not always readily separable -- and some courts have on this basis rejected
19
the notion that ERISA preemption can be cabined to “coverage” disputes.
Nevertheless, it is probably fair to say that in most jurisdictions, MCOs covered
by ERISA preemption can nevertheless be reached for physician malpractice to
the extent that they would otherwise be held liable under the conventional rules
of vicarious liability.
The expansion of vicarious liability for physician malpractice under state
agency law has not been matched by a judicial willingness to recognize a Federal
cause of action against the MCO under ERISA. In Pegram v. Herdrich,20 a health
plan covered by ERISA provided for treatment by non-HMO physicians only in
emergencies. The patient’s HMO physician decided that her condition was not
serious enough to justify an emergency ultrasound procedure at an unaffiliated
hospital, and the patient suffered a ruptured appendix as a consequence. In
addition to a conventional malpractice claim, the plaintiff argued that her injury
resulted from an incentive device within the HMO that rewarded physicians for
reducing costs by, inter alia, cutting back on referrals to physicians outside of the
HMO. This physician compensation system had not been disclosed to plan
subscribers, and its non-disclosure was alleged to be fraud under state law. The
state court held that the fraud allegation was preempted, and the patient then
filed in Federal court claiming that the HMO had committed a breach of its
fiduciary duty under ERISA (precisely how was somewhat unclear). In the
Seventh Circuit, Judge Coffey held that the MCO could be held liable for breach
of fiduciary duty to the extent that it relied on cost-control devices to limit a
21
subscriber’s consumption of medical services. The case created much of a stir at
the time because it branded as unlawful cost-containment devices that were in
22
It was no surprise therefore that the
common use in virtually all MCOs.
19

For example, in Pegram, the Supreme Court in analyzing the “dual
medical/administrative roles of HMOs” described in Dukes, 57 F.3d at 361, found that “[i]n
practical terms, these eligibility decisions cannot be untangled from physicians’ judgments about
reasonable medical treatment . . . .” Pegram, 120 S. Ct. at 2152-55.
20
120 S. Ct. 2143 (2000).
21
154 F.3d 362 (7th Cir 1998).
22
See, Herdich v. Pegram, 170 F.3d 683, 686 (7th Cir. 1999) (Easterbrook, J. dissenting). For
pointed criticism, see David Hyman, Medicine in the New Millennium: A Self-Help Guide for the
Perplexed, 26 Am. J. Law & Med. 143-150 (2000).
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Supreme Court reversed the Seventh Circuit and held that decisions within a
health plan that involve medical judgment, such as whether an emergency exists
that would trigger coverage at an unaffiliated hospital, are not “fiduciary”
decisions and thus cannot result in a breach of fiduciary duty. The Court thus
created a substantial roadblock for plaintiffs who would transform their state
malpractice claims into Federal ERISA claims (which, among other things, would
allow them to recover attorneys fees). The Court also observed that cost-cutting
devices were central to the operation of HMOs, and strongly hinted that the
mere existence of a particular cost-cutting scheme could not support a claim for
23
breach of fiduciary duty.
It remains to consider the division of liability between the MCO and the
physician in cases where both are liable for the physician’s malpractice. Their
liability is joint and several, so the plaintiff can collect the judgment from either
or both defendants as the plaintiff wishes, subject to the constraint that the total
amount collected cannot exceed the total judgment.24 Under the common law of
vicarious liability, employers who pay judgments because of torts by their
employee or independent contractor have a right to seek “indemnity” from
25
them. That is, the employer may sue the employee or independent contractor
for the amount paid out by the employer, and collect up to the limit of the
employee’s or independent contractor’s assets. In addition to this common law
right to indemnity, employers and their employees or independent contractors
are generally allowed to allocate the risk of liability between themselves by
contract. Although any contractual allocation of liability will not be binding
against a successful plaintiff in the face of joint and several liability, it will allow
the employer and its employee or independent contractor to shift the liability
between themselves after the plaintiff has collected so that the ultimate liability
falls wherever the parties to the contract wish it to fall.
2. MCO Liability for Wrongful Denial of Coverage
All courts seem to agree that disputes over the coverage of an employee
benefit plan “relate to” the administration of the plan and thus come within
ERISA’s general preemption clause. Another part of ERISA, however, exempts
from preemption the “state regulation of insurance.”26 But the Supreme Court
23

After noting that “inducement to ration care goes to the very point of any HMO scheme,”
the Court repelled from the potential consequences of the fiduciary claims: “Recovery would be
warranted simply upon showing that the profit incentive to ration care would generally affect
mixed decisions, in derogation of the fiduciary standard to act solely in the interest of the patient
without possibility of conflict.” The court found that this could lead to the reorganization or
elimination of HMOs, a decision it averred to be best left to the legislative branch. Id. at 2150, 56.
24
For an explanation of joint-and-several liability, see Richard A. Epstein, Torts § 9.2 & n.19
(1999).
25
Id., § 9.8 (citing Restatement (Second) of Torts §886B & cmt. e.).
26
29 USC §1144(b)(2)(A).
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has also held that the civil enforcement provisions of ERISA (the provisions that
afford plan beneficiaries a private right of action for denial of benefits) were
intended by Congress to be the exclusive remedy for employees suing over a
27
denial of benefits. Thus, when a dispute arises between a patient and an MCO
over a coverage matter, the first question is whether the MCO’s activities are part
of an employer-sponsored plan covered by ERISA. If the answer is no, then state
law applicable to such contractual disputes will govern. If the dispute involves a
plan covered by ERISA, state law is preempted unless it is part of the state law
“regulating insurance.” Even then, it will preempted to the extent that it
purports to provide any “remedy” for the denial of benefits (as distinguished
from, say, a rule of insurance contract construction).
The practical consequence of this convoluted structure is that a civil
enforcement action under ERISA is presently the sole legal remedy available to a
patient who challenges the denial of coverage by an MCO under a plan covered
by ERISA. The fact that the plaintiff is confined to the ERISA cause of action may
28
not make much difference on the question of liability, but it can have profound
impact on the remedy available to the successful plaintiff. Under ERISA, the
successful plaintiff is entitled to an order directing the plan to provide the
29
benefits in dispute, plus attorney’s fees. Or if the employee has paid for the
30
covered benefits out of his own pocket, he can obtain reimbursement. Most
critically, however, consequential damages are not allowed. Thus, if the denial
of coverage leads to unfortunate medical consequences, there is no recovery for
any pain and suffering, lost wages, wrongful death, loss of consortium and the
like, and no recovery of punitive damages.31
Under state law, by contrast, consequential damages may be recoverable
as long as they are “foreseeable” by the party who breaches the contract,32 at least
in those cases where the defendant has not successfully disclaimed consequential
damages, which is difficult, if not impossible to do, in connnection with the
33
personal injuries. The foreseeability hurdle seems likely to be a modest one
where an MCO has denied coverage for some treatment of medical importance
to the patient. In addition, many states now allow punitive damages against
insurers who deny coverage without a reasonable basis for doing so (denial of
27

Pilot Life, 481 U.S. at 52.
To be sure, there may be some differences between ERISA law and state law that will
affect the determination of whether or not the MCO has breached its contract with the plaintiff.
29
29 USC §1132(g)(2)(D).
30
29 USC §1132(g)(2)(A).
31
See also, Pilot Life, 481 U.S. at 53-54 (finding that ERISA does not permit punitive
damages) (citing Massachusetts Mutual Life Ins. Co. v. Russell, 473 U.S. 135, 147 (1985) (quoting
Northwest Airlines, Inc. v. Transport Workers, 451 U.S. 77, 97 (1981)).
32
Hadley v. Baxendale, 9 Ex. 341, 156 Eng. Rep. 145 (1854).
33
See U.C.C. § 2-719 (3).
28
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coverage in “bad faith”). The Supreme Court held in Pilot Life that the state law
cause of action for bad faith was indeed preempted by ERISA, but state courts
have allowed that action against MCOs in circumstances where ERISA
34
preemption did not apply.
3. Statutory Initiatives at the State Level
Public dissatisfaction with managed care has led to a number of initiatives
in the state legislatures, some of which affect the civil liability of managed care
organizations. In California, for example, an MCO will have “a duty of ordinary
care to arrange for the provision of medically necessary health care service to its
35
subscribers and enrollees . . . .” Liability attaches to any careless decision that
results in the “denial, delay or modification” of a service recommended for, or
furnished to, a subscriber who suffers “substantial harm” as a result.36 Georgia
requires “ordinary diligence” in reviewing claims for health benefits, and
37
imposes liability for injuries that result from a want of care. In Texas, an MCO
“has the duty to exercise ordinary care when making health care treatment
38
decisions.” An MCO is also statutorily liable for the health care treatment
39
These statutes
decisions of its employees, agents and ostensible agents.
generally indicate that they do not impose liability for the failure to provide a
service that is not covered by the benefit plan in question, but only for negligence
40
in the delivery of covered services.
Another common provision in these state initiatives prohibits
indemnification clauses that would require affiliated physicians to reimburse an
41
MCO for liabilities it incurs for breach of its duty of care, as well as a provision
that prohibits MCOs from retaliating against physicians that advocate particular
treatments on behalf of their patients.42 Some statutes also prohibit waiver of the
MCO’s duty of care, at least by subscribers or enrollees43 and in some cases by
44
employers as well. A few states have also enacted statutes that require MCOs
34

See, e.g., McEvoy, 570 N.W.2d at 406 n.6 (enforcing common law tort of bad faith against
HMOs where ERISA preemption did not apply).
35
Cal. Civ. Code §3428(a) (West, WESTLAW through 1999 portion of 1999-2000 Reg. Sess.
and 1st Ex. Sess.).
36
See, id. §3428(a)(1)-(2).
37
Ga. Code Ann. §51-1-48 (LEXIS through the 1999 General Assembly).
38
Tex. Civ. Prac. & Rem. §88.002(a) (LEXIS through the 2000 Supp. (1999 Sess.)).
39
See, id. §88.002(b)(1)-(4).
40
See, e.g., id. §88.002(d).
41
See, e.g., id. §88.002(g); see also, Cal. Civ. Code §3428(d); and Conn. Gen. Stat. §38a-472a
(LEXIS through 1997-98 Sess.).
42
See Tex. Civ Prac. & Rem. §88.002(f). See also, Okla. Stat. tit. 63, §2528.5 (LEXIS through
1998 Second and 1999 First Ext. Sess.) (prohibiting retaliation against physicians who testify at
internal or external reviews on behalf of patients in coverage disputes).
43
See, e.g., Cal. Civ. Code §3428(f).
44
See, e.g., Ga. Code Ann. §51-1-48(b).

MCO E/S

December 12, 2000

10

to afford subscribers an opportunity to obtain an independent review of any
45
decision to deny coverage.
In the absence of amendments to ERISA, it is uncertain how many of these
statutes can survive challenge on grounds of ERISA preemption. Statutes that
merely codify the common law of vicarious liability for malpractice are likely to
survive preemption challenges. Statutes that create state causes of action for the
denial of benefits under plans covered by ERISA, or require that independent
review procedures to be followed after a denial of benefits, are likely to be
preempted on the grounds that ERISA’s civil enforcement provisions provide the
46
exclusive remedy for aggrieved subscribers.
The gray area concerns the statutes that impose a duty of care on MCOs to
provide covered services in a timely manner, and that prohibit indemnification
clauses, retaliation against physicians, and waiver of statutory protection. A
Texas statute containing such provisions (except the no-waiver provision)
survived a preemption challenge in the Fifth Circuit.47 The court reasoned that
the statute really does no more than impose vicarious liability for malpractice,
given its stipulation that it does not in any way expand “coverage” under health
plans.
Likewise, the anti-indemnification provisions and anti-retaliation
provisions do not compel any particular level of coverage, the court argued, but
simply regulate MCOs in the interest of patient safety, much like state
malpractice law. The soundness of this reasoning may certainly be questioned.
Suits alleging a want of ordinary care in a decision made by an MCO will very
often implicate issues of coverage (such as the question whether an emergency
existed in Herdrich), and state actions regarding coverage are generally held to be
preempted as noted. The problem is even more acute with statutes (such as
Georgia’s) that require “diligence” in claims processing, and that may well lead
to lawsuits over delays relating to uncertainties about coverage. Likewise, antiindemnification and anti-retaliation provisions effectively constrain the terms on
which MCOs can offer health care coverage to employers, and may thus be said
to “relate to” the benefit plans quite directly. Absent legislative clarification at
the Federal level, therefore, these issues may require guidance from the Supreme
Court.
4. Federal Initiatives -- the “Patient’s Bill of Rights”
The U.S. Senate and House of Representatives are presently considering a
number of competing versions of a “Patient’s Bill of Rights,” aimed largely at the
45

See, e.g., Okla. Stat. tit. 63, §2528.5.
See Corporate Health Insurance, Inc. v. Texas Department of Insurance, 2000 WL 792435
(5th Cir. 2000) (holding that Texas statute requiring independent review of claims denials was
pre-empted).
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Id.
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managed care industry and the problems it is perceived to have created. Much
of the proposed legislation concerns the scope of coverage offered by MCOs, and
would have little direct effect on the civil liability of managed care organizations.
One of us has already written at some length on these proposals with a critical
48
eye. A few of the provisions do affect the liability of MCOs directly, however,
and warrant attention here.
One Senate Bill, S. 1344, would revamp the disclosure obligations under
ERISA, and require plans to provide considerably more information to
subscribers than presently. Among other things, plans would have to disclose
the way in which physicians are compensated, including any incentives for cost
49
reductions that might come at the expense of patient care (recall Herdrich). The
Bill would also impose new requirements regarding the procedures for denial of
claims by an ERISA-covered health plan. In particular, an internal appeals
process is required along with an option for a subsequent independent review,
and each procedure is regulated as to its timeline. Failure to adhere to the
timeline or to respect the results of an outside review is punishable by fines, and
patients can seek reimbursement plus attorneys fees for any services that the
plan should have covered but did not.
Other proposals, such as H.R. 2990, contemplate more extensive changes.
Like S.1344, this Bill introduces new requirements respecting the procedures for
the denial of claims, including internal appeals and the option for an
independent review,50 and it would also enhance the disclosure requirements
51
under ERISA. But it adds an anti-retaliation provision, similar to those enacted
at the state level, to protect physicians who advocate care on behalf of their
patients.52 And perhaps most importantly, it would amend ERISA’s preemption
provisions to provide that actions under state law may be brought for personal
injury or wrongful death against any person “in connection with the provision of
insurance, administrative services, or medical services by such person to or for a
group health plan...”53 If enacted, this language would plainly protect many of
the recent state initiatives from a preemption challenge. It goes on to provide
that in such actions, punitive damages may not be recovered as long as the
health plan has complied with the requisite procedures for internal and
54
independent review of claims denial.
B. Analysis
48
49
50
51
52
53
54

Richard Epstein, Managed Care Under Siege, 24 J. Medicine & Philosophy 343 (1999).
S. 1344, 106th Cong. § 111 (1999).
H.R. 2990, 106th Cong. §§ 1101-04 (1999).
Id. §1121.
Id. §1135.
Id. § 1302.
Id.
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The extant and proposed rules governing MCO liability are complex and
raise a number of distinct normative issues. It is helpful to divide them into
three broad categories: (1) the wisdom of imposing vicarious liability on MCOs
for the malpractice of affiliated physicians in accordance with state agency law;
(2) the wisdom of efforts to introduce a new remedy for wrongful denial of
coverage in addition to or in lieu of the existing civil enforcement action under
ERISA; and (3) the wisdom of various measures that constrain freedom of
contract between MCOs and their physicians or subscribers, including antiindemnification rules, anti-retaliation rules, and rules that prohibit waiver of
statutory duties.
1. Vicarious Liability for Malpractice
Economic Background. Vicarious liability responds to two potential
problems.55 First, the financial assets of many employees are insufficient to cover
judgments against them for the torts that they commit in the course of their jobs.
If employees are unable to pay judgments, they may lack the incentive to invest
in the efficient level of care to avoid accidents. In addition, if employees lack the
assets to pay judgments, their wage demands may not reflect the full extent of
their expected liability. Business enterprises will then avoid paying the full cost
of harms that they cause, and the scale of risky activity may become inefficiently
large. Finally, because a contractual assumption of liability by the employer
would put more assets at risk, employers and employees may elect to leave the
liability on the employee even when the employee is risk averse and the
employer is the superior risk bearer. For essentially the same reason, risk averse
employees may elect not to buy any liability insurance and instead to take their
chances on bankruptcy.
Vicarious liability can ameliorate these inefficiencies. By placing the
employer’s assets at risk, employers will have an incentive to exercise whatever
control they have over their employees to induce them to behave more carefully,
and the joint incentive to invest in care will be optimal as long as the combined
assets of the employer and employee are sufficient to cover judgments against
them.56 If employers can observe carelessness directly, they can require careful
behavior as a condition of employment. Where care is not directly observable at
all times, a moral hazard arises but other monitoring devices may nevertheless
be employed to induce employees to be more careful than they would be
otherwise. Threats of discharge or demotion in the event of accidents, spot
55

The general analysis of vicarious liability is developed at length in Alan O. Sykes, The
Economics of Vicarious Liability, 93 Yale L.J. 1231 (1984). For an account of the rules, see Richard
A. Epstein, Torts § 9.9 & 9.10 (1999).
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This proposition assumes that damages judgments are equal to the social value of the
harms caused by employees.
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checks for the level of care, and perhaps the threat of an indemnity action can
combine to enhance the employee’s incentives for care.
In addition, vicarious liability forces the business enterprise to internalize
the costs of harms that it causes. It thus tends to reduce the scale of risky activity
57
to the proper level.
Finally, because a contractual assumption of liability by the employer no
longer has the effect of placing more assets at risk, vicarious liability eliminates
the possible incentive to leave liability inefficiently on a highly risk averse
employee. Likewise, if the risk is better laid off on the insurance market, there is
no longer any disincentive to doing so, and indeed the employer may be the best
party to purchase insurance, buying a single policy to cover everyone in the
workforce.
Putting aside the possible insolvency of the employee, a second potential
problem in the absence of vicarious liability -- albeit a less important one -- arises
where the transaction costs of contracting between employers and employees
impede a contractual allocation of risk between them. The rules of vicarious
liability can then serve as potentially useful “default” rules, allocating the risk of
liability to the employer or the employee, as the case may be, in accordance with
which of them is likely to be the better risk bearer.
A third rationale for vicarious liability also deserves mention. In many
business situations, it is clear that the harm in question has been caused by some
employee or employees, but it is not clear by which.58 Absent vicarious liability,
the firm can hide behind the inability of the injured party to identify the
individual wrongdoer, thus leading to systematic underdeterrence of the wrong.
This problem can be effectively avoided by vicarious liability no matter whether
the risk was caused jointly or individually by workers. And once vicarious
liability is imposed, the firm has strong incentives to keep track of the behavior
of its own employees.
Vicarious liability will be of little benefit, and may simply increase
litigation costs, when the above conditions that favor it do not arise. Thus, if
there is no potential insolvency on the part of employees, little reason to think
that employers are the superior risk bearer, and no causal uncertainties, vicarious
liability is likely undesirable. Similarly, if employers have little ability to induce
their employees to behave more carefully, the benefits of vicarious liability are
lessened.
57

The caveat is that if liability is only for negligence, any harms that occur when due care is
taken will still be externalized. Of course, under a rule of strict liability, a reverse externality runs
from victims to injurers. Ronald H. Coase, The Problem of Social Cost, 3 J.L. & Econ. 1 (1960).
58
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One of us has argued elsewhere that the common law rules of vicarious
59
liability are broadly responsive to these economic considerations. The doctrine
of respondeat superior tends to impose liability on employers when employees
have limited assets, and when employers have monitoring techniques available
to them to induce employees to behave more carefully. The typical employee for
whom employers are held liable may also be quite risk averse and thus a poor
risk bearer. The general rule that employers are not liable for torts by their
independent contractors can similarly be justified on the grounds that
independent contractors tend to have more substantial assets (often including
their own liability insurance), that the ability of employers to monitor them and
induce greater care is much weaker, and that there is often little reason to believe
that the employer is less risk averse.
Application to MCOs. At times, it may well be efficient for entities such as
hospitals and MCOs to bear vicarious liability for physician malpractice. The
young resident or intern, for example, on salary at an HMO hospital, may well
have limited assets and be unlikely to purchase adequate malpractice coverage if
left to her own devices. In addition, the young physician may well require (and
receive) considerable supervision by more senior physicians to avoid errors in
care, so that the HMO hospital has considerable capacity to monitor her. On
these assumptions, the standard arguments for vicarious liability apply readily.
When physicians establish independent practices and carry substantial
malpractice insurance on their own, by contrast, the case for vicarious liability is
much weaker. The physicians’ personal assets, including malpractice coverage,
become considerable and the problem of potential insolvency greatly diminishes.
Further, the ability of hospitals or MCOs to monitor these independent
physicians is extremely limited, as there is no one with greater medical expertise
in the hierarchy regularly overseeing their work. We thus doubt that vicarious
liability for independent physicians with their own malpractice coverage will
accomplish much beyond adding an additional party to litigation, which of
course is costly in itself. And the likely result of vicarious liability under these
circumstances may simply be an effort to shift the liability back to careless
physicians by contract (if that is allowed, as we discuss below).
To a degree, the application of standard common law principles to MCOs
and their affiliated physicians will track this economic logic. Vicarious liability at
common law is likely to be imposed for malpractice by a physician on salary at a
hospital or HMO. By contrast, a physician who has an independent practice and
her own malpractice coverage is likely to be deemed an independent contractor,
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and any hospitals or MCOs with which the physician is affiliated will ordinarily
not be subject to vicarious liability.
Certain exceptions to this “independent contractor rule,” however, have
60
As noted earlier,
been at the heart of much recent litigation in the area.
plaintiffs can reach beyond the negligent physician on a theory of “implied
agency” or “ostensible agency.” Both of these doctrines, in the abstract, have
some logic as traditionally applied at common law. Where an “independent
contractor” is in fact controlled by another entity in making decisions about care
(the “implied agency” case), the imposition of liability on that entity may be
desirable to help promote proper incentives for care. If the independent
contractor has substantial assets at risk, of course, he may seek a contractual
assumption of liability by the entity that exercises control, and the imposition of
vicarious liability may be superfluous. But whether it is accomplished by
contract or by the common law, it makes good sense for the party who selects the
level of care to bear the risk of error. Likewise, liability for the “ostensible agent”
makes sense where the public is induced to deal with a particular independent
contractor on false pretenses. The paradigm case here would be one in which the
public is led to believe that an impecunious independent contractor is in fact an
employee of another entity, so that the apparent employer’s assets would be
available to satisfy a judgment in the event of carelessness by the apparent
employee. The actual cases that have been litigated often deny independent
contractor status to groups of emergency physicians who appear to the outside
world to be an operating division of the hospital or medical center of which they
are a part.61
In principle, either scenario might justify the imposition of liability on an
MCO for independent contractor physicians. In practice, however, we doubt
that the conditions justifying such liability will be satisfied very often.
The fact that an MCO exercises some independent judgment about the
medical necessity of particular care, for example, or utilizes some cost control
device that makes physicians think twice about ordering expensive procedures,
is quite insufficient in our view to convert the physician into an “implied agent”
anytime a malpractice allegation arises. As long as the care decision resides with
the independent contractor physician, economic logic suggests that liability
should reside with that physician as well. It is only when the MCO overrules the
physician and dictates a course of care contrary to the physician’s
recommendations that a shift of liability may be warranted. Indeed, the
physician may have a defense to a malpractice claim in such cases, and it may
then become quite important that a patient have a distinct cause of action against
60
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See Petrovich, supra.
Hardy v. Brantley, 471 So.2d 358 (Miss. 1971).

MCO E/S

December 12, 2000

16

the MCO -- we return to this issue below when we discuss actions relating to
denial of coverage. But putting aside this class of cases, findings of implied
agency against MCOs are likely inappropriate.
Likewise, claims of “ostensible agency” typically ring quite hollow. The
independent contractor physicians who affiliate with MCOs are not in general
impecunious, and rarely can the argument be made that they are unable to pay
for their torts. Nor is it often plausible that patients have been induced to deal
with these physicians on the false premise that the MCO has somehow certified
their financial soundness. The mere fact that the physicians are part of a network
or HMO, and that the details of their affiliation with the MCO are not widely
disseminated, are wholly insufficient to induce the sort of mistaken reliance on
the physician’s status hat might justify a finding of ostensible agency.
If we are right that insolvency is usually not a serious concern with
independent contractor physicians, however, why are plaintiffs’ lawyers so
interested in reaching the MCOs as well? The answer, we suspect, as noted
above, is that the MCO is a much less sympathetic defendant than the individual
physician. Juries will be more generous with their compensatory awards, and
more disposed toward punitive awards, when the faceless, cost-cutting MCO is
implicated as contributing to the plaintiff’s bad medical outcome. Unless one
believes that juries undercompensate today in malpractice cases involving
individual physicians, therefore, adding the MCO to the mix may result in
nothing more than an excessive award and additional litigation costs that will
reduce the capacity of MCOs to control expenses in the interests of all.
The effort by the plaintiff in Herdrich to convert a garden variety
malpractice claim into a claim for breach of fiduciary duty under ERISA raises
still further concerns. Some of the remedies for breach of fiduciary duty -- such
as disgorgement of profits -- simply do not fit well with the malpractice action.
Damages to compensate the plaintiff for his injuries, and thus to encourage the
care-provider to internalize the costs of mistakes, are more appropriate. And
while one can wonder about the wisdom of the American rule regarding
attorneys fees in tort actions generally, there is no reason to depart from it simply
because a physician happens to be affiliated with an MCO.
In sum, when the physician qualifies as an independent contractor under
agency law and has substantial malpractice coverage of her own, we believe that
efforts to impose vicarious liability on the MCO because of implied or ostensible
agency should generally be
rejected. The significant class of exceptions arises when the MCO has refused to
permit the physician to provide the care that the physician recommends, and
that decision has arguably caused the harm to the plaintiff. As this situation is
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more properly viewed as a coverage dispute than as a malpractice claim, we deal
with it separately below.
2. Liability for Wrongful Denial of Coverage
Because of ERISA preemption, many participants in MCOs are limited to a
civil enforcement action under ERISA when challenging the denial of benefits by
their health plans. As noted, the ERISA remedy simply allows the successful
plaintiff to obtain an order directing the plan to provide the benefits, or to
reimburse the plaintiff for services purchased elsewhere, plus attorneys fees. No
consequential damages are allowed, even if the wrongful denial of coverage
resulted in great pain and suffering or even death.
It is not difficult to fashion an argument that the ERISA remedy is
inadequate. Because the premiums charged by health plans to employers and
subscribers are generally fixed at an amount that is independent of the care
provided, the argument runs, reduced expenditures on care mean more profits
for the health plan. A plan that wrongfully denies benefits at a minimum defers
an expenditure and captures the time value of the money, even if the sums saved
today eventually be spent tomorrow. And if the patient does not have the sense
or wherewithal to challenge the denial effectively, the wrongful denial is pure
gain. A self-serving health plan may balance the prospect of paying plaintiff’s
attorney fees at the end of litigation against the benefits of delaying an
expenditure or perhaps avoiding it altogether, and might conclude that a
deliberate, wrongful denial of benefits is a good bet. Indeed, the calculus may be
even more favorable toward wrongful denial if the plan anticipates that it can
settle the cases that are brought quickly with minimal expenditures necessary to
compensate plaintiffs’ attorneys.
The problem is not limited to deliberate, wrongful denials. Callous or
overworked plan administrators may also deny benefits without exercising
sufficient care to ascertain whether they should be provided. These careless
denials of benefits may work great harm to a subscriber in medical need, and
because the consequential damages associated with such harms are not
recoverable, carelessness in processing claims for or in authorizing treatment
may be seriously underdeterred. To provide proper deterrence of such behavior,
the argument runs, the plan must be made to pay for the harms that are caused
by wrongful denial of benefits, whether deliberate or careless. Only an award of
consequential damages, in addition to the current relief provided by ERISA, will
achieve that objective. And of the legal initiatives discussed earlier, only a
Federal statute can provide the needed changes in ERISA.
This argument has considerable force, and may in the end be convincing.
But we add some important cautions. First, the notion that ERISA-covered plans
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can deny benefits willy-nilly without significant penalty is plainly exaggerated.
If administrators regularly deny valid claims or authorization for treatment,
employers will hear about it and will be strongly urged by their employees to
change health plans. Word of such behavior can also disseminate across firms as
human resources administrators communicate with each other. In short, the
usual market constraints associated with repeat dealing and reputation are
operative to a significant degree, even if they do not eliminate all problems.
Second, changes to the available remedy will no doubt introduce new
error costs. In the malpractice area, scholarly studies suggest that the courts are
rather poor at identifying malpractice -- many bona fide cases of malpractice are
overlooked, while lawsuits often focus on cases where the physician did nothing
62
wrong. The question whether the denial of a claim or an authorization for
treatment was wrongful may not raise quite the same issues, but certainly raises
related ones. The plan’s judgment about medical necessity, or the existence of an
emergency, will often be at the heart of a dispute (as the Supreme Court noted in
Herdrich). And given the diversity of medical opinions on the proper course of
treatment for particular patients, it may not be difficult for a plaintiff to find an
expert willing to opine that some treatment was “necessary” or “nonexperimental.” Juries may be no better at sorting out such complicated issues,
and no less inclined to help out the sympathetic plaintiff, than they are in
standard malpractice cases. One must therefore wonder whether erroneous
judgments against health plans might increase the costs of care significantly and
discourage greatly efforts at cost control.
Third, we note the practice of contracting away from consequential
damages is routine in virtually all sales transactions governed by the Uniform
Commercial Code and similar statutes. The same pattern appears whether the
transactions are between merchants or, as is the case here, between merchants
63
and consumers. Given the range of transactions that adopt the same position,
we think that is unlikely that the uniform practice could be attributable—much
less attributable solely—to some defect in market structure or to some systematic
want of information by the consumer party. Rather we think that it is likely that
some of the economic pressures that produce these contracts between
commercial equals can also operate here. Certainly the need to control
62
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administrative costs, reduce error, and to prevent the implicit cross-subsidy
between those plan members that are likely to protest from those who are
compliant has a lot to do with the overall picture.
However one comes out on the broader issue of whether to amend ERISA
to permit higher damages awards, we have particular concerns about some of
the recent changes in state law noted earlier. Recall that a number of the state
statutes impose a duty of ordinary care on MCOs, noting that they do not
expand the “coverage” of benefit plans, while the courts continue to suggest that
the sole remedy for a denial of coverage is a civil enforcement action under
ERISA. This situation invites some unintended complications. Consider an
employer-sponsored health plan that has initially refused to cover or authorize
some treatment that a subscriber wants. After further consideration, the plan
changes its mind and is willing to pay for the treatment in question, but in the
meantime the patient has suffered some harm because of the delay. If the plan
admits that the treatment was “covered” all along, it opens itself up to a state
action for breach of its duty of care. By contrast, if the plan stonewalls in its
original position and insists that the treatment is not “covered,” it has an
argument that the sole remedy is the ERISA civil enforcement action.
Accordingly, the incentive may be for the plan that initially denies coverage to
fight tooth and nail to defend its denial, even if it later comes to believe that it
made a mistake. The unintended consequences for subscribers may thus be quite
unfortunate.
The question also arises whether state actions for “bad faith” denial of
benefits, which in some jurisdictions allow the recovery of punitive damages,
should be allowed if ERISA is amended. One argument for punitive damages
against insurers who breach first-party insurance contracts is that in their
absence, insureds with high subjective discount rates would be induced to settle
for considerably less than they are entitled to under their insurance contracts. In
other words, insurers will exploit their insureds’ desperate need for money to
induce them to settle for a smaller sum than they should properly receive -- the
prospect of compensatory damages at the end of a long litigation is an inferior
64
At first blush, this argument might seem applicable to MCO
alternative.
subscribers, who may desperately need particular care to improve their quality
of life or even to survive. But on further reflection, the desperation of a seriously
ill patient is not likely to induce the patient to settle for less than the care that he
believes is necessary to make him well. When the issue is what health care will
be provided, as opposed to what amount of money the insured will accept to
settle a monetary claim, it is not clear that an insurer can exploit the insured’s
64
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high “discount rate.” The argument for punitive damages to prevent such
exploitation then carries little weight.
Another more familiar argument for punitive damages is that they can
correct for an underdetection or underenforcement problem. Applying the
argument to MCOs, the theory would be that when an MCO denies benefits
wrongfully, the denial will be challenged with probability less than 1.0. If
damages are merely compensatory, the argument runs, the expected cost to the
MCO of wrongful denial is less than the actual cost to subscribers on average,
and too much of it will occur.
This argument is more convincing, as it simply requires a degree of
ignorance on the part of MCO subscribers that would lead them to forego
treatment to which they are entitled with some regularity. But even here we
could expect some increased level of consumer awareness, given the high stakes
to the parties, and the presence of aggressive intermediaries (unions,
cooperatives, lawyers, public officials) who will take steps to inform plan
members of their statutory rights. Further, if an argument for punitive damages
may be fashioned along these lines, it is important that they be calibrated
sensibly. The goal should be to correct for any underenforcement problem, and
the difficulty is that punitive damages for “bad faith” are not calibrated to that
end. Juries are told to look at factors such as the egregiousness of the
65
None of these factors bears
defendant’s conduct and the defendant’s wealth.
much relationship to the underlying issue. Hence, there can be little confidence
that allowing punitive damages to be assessed against MCOs under existing state
law would improve matters. It is noteworthy that H.R. 2990 (and some of the
other bills introduced in Washington) would protect MCOs against punitive
damages as long as they comply with certain appeal procedures for subscribers
who challenge a denial of benefits.
3. Limitations on Contracts with MCOs
With proper remedies in place for malpractice and for wrongful denial of
coverage, there is little basis for interfering with the ability of MCOs, physicians
and employers to allocate liability risks by contract. Accordingly, antiindemnification rules, anti-retaliation rules and rules against waiver of new
causes of action are suspect.
Anti-Indemnification Rules. The typical anti-indemnification rule under
recent state statutes, as noted, prohibits MCOs from pursuing indemnity against
65
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affiliated physicians after the MCO has been held liable for breach of its duty of
care. The prohibition applies even if the contract between the physician and the
MCO expressly provides for indemnity. The argument for such rules, we
suppose, is that the MCO will otherwise exercise its “bargaining power” to force
physicians to accept an indemnity agreement that is not in the best interests of
physicians and their patients. The MCO will avoid having to pay for its own
intentional misconduct or carelessness, resulting in an undesirable increase in
such behavior by the MCO.
Such arguments are familiar from other settings, and almost always
deeply flawed for essentially the same reasons. An MCO will wish to include an
indemnity arrangement in its contract with physicians only if it profits from the
arrangement. Physicians have reservation wages just like all other participants
in labor markets, and if an MCO requires physicians to indemnify it against
liability, that reduces the level of physician compensation, other things being
equal. The MCO must then pay physicians more direct compensation to induce
them to affiliate with the MCO. The indemnity arrangement will be desired by
the MCO, therefore, only if the increase in direct compensation that it
necessitates is less than the expected value of the MCO’s own liability in the
absence of the indemnity arrangement. In turn, the required increase in direct
physician compensation under an indemnity arrangement will be at least equal
to the expected value of the indemnity payments that physicians must make.
Indeed, it may be considerably greater that that if the physician, whose portfolio
of risk is underdiversified, is risk averse and worried about the variance in her
expected income with an indemnity arrangement.
Suppose, then, that the indemnity arrangement indeed increases the
amount of wrongful behavior by the MCO, and increases the attendant liability
to subscribers, which is now borne by the physicians pursuant to an indemnity
agreement. In that event, the requisite increase in direct compensation to
physicians under the indemnity arrangement will exceed the direct costs of
liability to the MCO without an indemnity arrangement. If this were the case, it
would be irrational for the MCO to insist on an indemnity arrangement. The fact
that an indemnity arrangement is commonly observed suggests that the parties
to the contract expect it to lower, not increase, their joint liability to subscribers.
And that will be true only if it reduces, not increases, the damages payable as a
result of the wrongful behavior by the MCO. Notice that this argument in no
way turns on any assumptions about the relative “bargaining power” of MCOs
and physicians.
A possible objection to the above reasoning relates to the information
available about the value of indemnity.
If physicians systematically
underestimate the expected cost of indemnity to them, they may “sell”
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indemnity agreements too cheaply. MCOs might then profit from them even if
they increased the harm from actionable negligence. But we can imagine no
basis for supposing that physicians will as a group underestimate the costs of
agreeing to indemnify MCOs.
Accordingly, we would expect any
indemnification arrangements negotiated with MCOs to be efficient rather than
inefficient.
The possible utility of indemnification is easy to see. Even where an MCO
has been found negligent for, say, refusing to provide some treatment on the
grounds that it is not “medically necessary,” affiliated physicians may well share
in the blame. The denial of coverage might result as much from the failure of the
physician to provide clear and credible justification for the recommended
treatment as from carelessness on the part of the MCOs decisionmaker. If so, the
value of inducing greater care on the part of physicians in making their
recommendations may exceed the costs of reducing the incentives for care within
the MCO.
The value of allowing indemnity actions may be even greater owing to the
dynamics of tort litigation. So long as the treating physician is protected against
suit by statutory prohibitions against indemnity actions, then she could easily
team up with the plaintiff in order to send, as it were, a message to the MCO.
Juries in many cases are reluctant to impose extensive liability against individual
physicians who live in their own communities, but that reluctance is likely to
vanish when it becomes possible “to send a message” to an impersonal or distant
corporation.
In short, the parties to the contract are better situated than anyone else to
determine what allocation of liability will minimize the losses from mistakes, and
the law should thus respect their allocation of liability. Blanket prohibitions on
indemnification arrangements, such as those found in a number of recent state
statutes, are unsound.
Anti-Retaliation Rules. These rules prohibit MCOs from punishing
physicians who advocate care on behalf of their patients. If adequate remedies
exist for wrongful denial of coverage, however, the costs to subscribers from
such behavior will be internalized by the MCO and its affiliated physicians.
When it appears that a physician has been the target of “retaliation” under these
circumstances, there is nevertheless no case for interfering with freedom of
contract between physicians and MCOs because no harm results to third parties
by hypothesis.
The caveat relates to the assumption that the remedy for wrongful denial
of coverage is adequate. We have already suggested in the last section that
changes in the ERISA remedy may be appropriate. Further, for an MCO
subscriber to establish that coverage was wrongfully denied, testimony from the
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subscriber’s physician will often be required. If MCOs are allowed to retaliate
against physicians who provide honest cooperation to a subscriber complaining
about a denial of coverage, therefore, the adequacy of the remedy may be
undermined. It may thus make sense for the law to prohibit retaliation against a
physician who provides helpful information to a subscriber seeking to secure
coverage through an internal or independent review process, or during a lawsuit
alleging a wrongful denial of coverage. The analogy is to rules that prevent an
employer from retaliating against an employee who reports a statutory violation
or who files a workers’ compensation claim. Broader anti-retaliation rules,
however, such as those in the Texas statute that prohibit retaliation for all
advocacy on behalf of patients (whether or not connected to the dispute
resolution process) may make it impossible for MCOs to rid themselves of
physicians whose medical judgment is regularly at odds with reasonable efforts
at cost containment.
Anti-Waiver Rules. Some state statutes restrict the capacity of parties who
deal with MCOs to waive their statutory rights of action. In discussing these
rules, it is useful to distinguish two variants -- those that make it impossible for
subscribers to waive their rights, and those that make it impossible for employers
to waive the rights of all employee-subscribers to a health plan.
The argument for preventing patients from waiving their rights is a
familiar one -- they may be induced to waive rights of action in some standard
consent to treatment form or other document filled with fine print, without ever
reading it or understanding it. They will then grant the waiver too cheaply (or
for nothing), and the valuable incentives created by the statutory cause of action
will be lost.
Although this concern perhaps justifies restrictions on the ability of
individual subscribers to waive their rights under a health plan, it is noteworthy
that such restrictions on waiver could be written into the plan itself. The market
can thus provide wavier restrictions if they are valuable. And if employers, who
are informed on these matters, do not seek them on behalf of their employees,
their utility is then in some doubt.
Our greater concern, however, is with restrictions on the ability of
employers to waive or limit causes of action against MCOs. Simple economics
suggests that employers have an interest in providing fringe benefits to their
employees when the employees will value them at an amount greater than the
cost to the employer. If waivers or limitations on rights to sue are inefficient, so
that the price to the employer for excluding them from the plan is exceeded by
the loss to the employees from including them, the employer’s self-interest
should lead to their exclusion.
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This simple argument assumes, of course, that employers and employees
collectively do not undervalue the right to sue ex ante, and agree to waivers or
other limitations too cheaply. One can imagine this problem occurring on
occasion, particularly with small employers that may have little sophistication in
employee benefits matters. But if large employers with substantial human
resources departments would agree to waivers or other limitations on suit, the
66
inference that they are harmful is largely dispelled.
The possible utility of agreements between employers and MCOs
to reduce the MCOs’ exposure to liability is again easy to see. If MCOs’ become
liable for consequential damages for negligently denying treatment to
subscribers, or punitive damages for “bad faith,” the potential costs to them of
denying treatment increase greatly. And as noted earlier, it would be a mistake
to suppose that courts can adjudicate these cases without error. Plaintiffs will
generally be sympathetic to juries and MCOs quite unsympathetic. We have no
way to know how serious this problem might become, but it is by no means
inconceivable that the costs of errors in the administration of a new remedy
might exceed its benefits. If at that point large employers prefer to agree to a
curtailment of the right to sue, the system should not prevent it, but should
instead take that development as a strong signal that things have gone awry.
II. The Class Actions
Few institutional practices in the modern legal scene invite sharper
differences of opinion than the modern class action. In the eyes of some, the class
action supplies the ordinary person the keys to the courthouse, which would
otherwise be inaccessible to individuals with small claims. To others, the class
action is a giant club that allows plaintiffs lawyers to extract large settlements
from defendants who fear adverse verdicts in “you-bet-your-company”
situations.67 Both over generalizations are dangerous. The broad subject matter
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Of course, even small firms can hire third parties to supply the expertise that they lack
internally.
67
See In re Rhone-Poulenc Rorer, Inc., 51 F.3d 1293 (7th Cir. 1995), in which Judge Posner
acting on a petition for mandamus ordered decertification of a class based in part upon
a concern with forcing these defendants to stake their companies on the outcome
of a single jury trial, or be forced by fear of the risk of bankruptcy to settle even if
they have no legal liability, when it is entirely feasible to allow a final,
authoritative determination of their liability . . . to emerge from a decentralized
process of multiple trials, involving different juries, and different standards of
liability, in different jurisdictions; and when, in addition, the preliminary
indications are that the defendants are not liable for the grievous harm that has
befallen the members of the class.
Id. at 1299. It is worth noting that since this decision, the Federal Rules of Civil Procedure have
been amended to include R. 23(f), which grants to circuit courts discretionary review of district
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range of class actions—antitrust, corporate derivative suits, consumer and
securities fraud, tort claims, breach of warranty—defies easy characterization. In
some contexts, the use of class actions seems relatively uncontroversial, but in
others, such as the suits against tobacco companies and MCOs, the use of class
actions is anything but. We begin our analysis with a brief review of the logic of
class actions, with attention to their benefits and pitfalls in various
circumstances.
A. The Costs and Benefits of Class Actions
The Plaintiff’s Perspective. Let us assume that an individual has a valid
claim worth $1,000 that costs $1,500 to collect. Under the American rule where
each side bears its own legal expenses, as a first approximation we can be
confident that suit will not be brought. The plaintiff who wins the action is
worse off than if he had never brought the case at all. That calculation, of course,
can be made far more complex by the introduction of a few confounding
variables. The defendant may have to spend $1,500 to defend the claim as well,
so that a well-timed demand letter by a plaintiff may elicit a payment or
settlement without having to incur the full $1,500 in legal costs. Yet the
defendant who knows the plaintiff’s cost structure may just ignore the demand,
believing that the plaintiff has no interest in forcing the defendant to lose $2,500
in fees and payments for the privilege of losing $500 himself. The basic
calculations only become more complicated when the plaintiff’s claim is of
uncertain validity or uncertain amount.
The basic assumption behind the class action is that the amalgamation of
individual claims will alter for the better the ratio between the size of the
anticipated recovery and the costs of obtaining it: the cost per unit claim drops as
the number of claims rises. Thus if 1000 claims are brought together, the total
size of the pot goes from $1,000 to $1 million. But the costs of bringing that
action may increase say by between 10 and 100 fold, to between $15,000 and
$150,000: all of a sudden the economics of suit from the plaintiff’s side start to
make sense, for the expected recovery exceeds the expected cost of litigation,
even for claims uncertain in validity and extent. The situation necessarily works
a stunning reversal in fortune for the defendant who could be saddled with an
adverse judgment of $1 million plus his own defense costs. But without more
that claim for mercy deserves little sympathy. The class action only makes
affordable underlying cases that were already valid. The real problem was the
prior inability of injured plaintiffs to counteract the defendant’s wrongful
conduct.

court orders regarding class certification, and thereby allows parties the opportunity to challenge
class certification without resorting to the more arduous standards required for mandamus.
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Yet overcoming that cost barrier introduces management problems of its
own concerning the relationship of the class to its individual members. Prior to
the class action, the initial legal position gives all individuals the sole and
exclusive ownership of all legal claims, including those for invasion of property,
personal injuries, fraud or breach of contract. It only makes sense that a cause of
action for injury to these protected individual interests should ordinarily go to
the individuals whose interests have been impaired, because they have the best
information about the issues surrounding the dispute, and they are the ones who
suffer the unanticipated drop in wealth from the incident. Vesting the claim in
the initial holder of the right also prevents endless competition over who
controls the suit, and helps to achieve both deterrence of and compensation for
injuries, generally regarded as the twin objects of the tort system.
The initial assignment of the claim to the individual plaintiff may be
overridden in response to the administrative complications alluded to above.
The value of the claim depends on the chances for its successful prosecution:
where the claim is large in amount and unique in content, the individual plaintiff
will normally be in the best position to decide whether to pursue it. But once the
claims become smaller in amount and larger in number, then the presumption
may have to give way but not absolutely. One way to understand the class
action is as a system of forced exchanges whereby the individual plaintiff
surrenders control of his or her claim in exchange for the benefit of fractional
class participation of equal or greater value.
The most obvious applications of this principle do not involve actions for
damages, but rather cases in which the relief sought is a class good (nonrivalrous
and nonexclusive) for the members of the class. Thus when an individual
shareholder seeks to enjoin or require particular actions from a corporate officer,
that decision will necessarily impact all shareholders in proportion to their
interest. A rule that allows an individual to prosecute only on his own behalf
thus allows other shareholders to free-ride on that decision. The class action
device, insofar as it allows the moving shareholder to recover legal fees
conditional upon the successful prosecution of the suit, is an effective counter to
the freerider problems, but does not seem to raise deep concerns about
individual autonomy given the close alignment of interests between the active
and the passive shareholders. And where those conflicts do arise, then some
method may be reached to allow certain shareholders, with notice, to opt out of
the class.
These questions of structural relief are part and parcel of the suits against
MCOs, many of which claim the need for structural reform of MCO practices for
the benefit of plan members. But these cases also seek monetary damages. Class
action damage cases do not give rise to the necessary freerider problem that
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arises in cases seeking injunctive relief. It is in principle possible for one person
to pursue his own claim while another individual may decide to settle or
abandon his suit. Indeed, it is just that possibility of separability, which allows
each claimant to pursue independent strategies, which makes the class action
68
most controversial in the case of damage actions. In this context, the case for
allowing class actions is necessarily different, and runs as stated above: the
surrender of the private right to suit is offset by the efforts taken by the class
representatives and their lawyers on behalf of passive class members, and the
associated economies of scale which reduce the per claim cost of litigation more
than enough to offset any costs of amalgamating claims and suppressing their
differences. That condition is most likely to hold when the class representatives
have claims typical of members of the class generally, when the lawyers who
have led the charge are capable of adequately representing both the named and
the unnamed plaintiffs, and when the common issues in the class are sufficiently
important and uniform so as to obviate potential conflicts of interests between
the class representatives and the remaining members of the class. The ability to
exit from the class and preserve the individual action is one check on the dangers
of conflict, and judicial oversight of the various decisions of the class
representatives and lawyers offers a second line of protection against abuse. It is
an open question in principle whether the administrative costs of running the
class actions—many of which fall on the public at large—are low enough to
justify the use of the class action mechanism in a given case. Among other
things, the system requires some degree of supervision over the attorneys’ fees
generated under the class action so that the lawyers receive only a competitive
rate of return on the services that they supply. And there are immense difficulties
in making sure that the class definition, the actions of the class representative,
and the decisions concerning whether to litigate or to settle are consistent with
keeping the passive members of the class better off than they would have been
had no class action been brought—and better off in roughly uniform proportion
with the named plaintiffs. That said, the general view is that the class action
survives a frontal assault against its very existence, whatever the abuses or errors
in its application to individual cases.69
68

For recognition of this point, See Fed R. Civ. P. 23(b)(3) advisory committee’s note (1966),
dealing with amalgamation of damage actions, which states that “[i]n the situations to which this
subdivision relates, class action treatment is not as clearly called for as in those described above,”
i.e. in sections 23(b)(1) and 23(b)(2).
69
A convenient summary of the protections is offered in Fleming James, Jr., Geoffrey
Hazard, Jr., & John Leubsdorf, Civil Procedure §10.22 at 564 (4th ed. 1992) (footnotes omitted):
Revised Rule 23 provides for court control of the representative’s conduct,
including giving notice to absent members of the class, allowing absentees to intervene,
subdividing the class into subclasses along the lines of their interest, limiting the issues as
to which the class proceeding shall be binding on absentees, and requiring court approval
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The Defendant’s Perspective. As already noted, the class action exposes
the defendant to liabilities greater than those which it faces in a setting where
only individual claims (even with permissive joinder) can be brought. When this
development follows solely from the consolidation of meritorious claims into a
single claim with lower aggregate litigation costs, defendants should not be
heard to complain. But the formation of the class gives rise to two other
potential disadvantages for defendants that are not so easily dismissed.
Substantive Law Transformation Through Claim Amalgamation. The first
danger involves the risk of some implicit transformation of the substantive law
during the course of claim aggregation. Thus, suppose that the plaintiff must
prove A, B, and C in order to win an individual judgment. The class action takes
on a far more ominous role if the requirement A is dropped, or if the burden of
proof on element B is switched from what it would be in an individual suit. Now
in effect the conservation of legal accountability (as we might call it) is not
respected in the amalgamation of claims in the class action format, and to that
imposition the defendant has a legitimate protest.
Just how powerful these transformations can be is illustrated by the
successes that plaintiffs had in the tobacco litigation, which proceeded through a
modified form of the class action.70 The usual tort claim in tobacco litigation
contained elements for pain and suffering, lost income and medical expenses.
of any settlement. In addition, members of a Rule 23(b)(3) class —the damages class suit
— may opt out by signifying that they do not wish to have their claims included in the
action. Revised Rule 23 thus appears fully to meet the requirements of Hansberry v. Lee,
on adequate protection of the absentees’ interests.
70
See, Agency for Health Care Admin. v. Associated Indus. of Florida, 678 So.2d 1239 (Fla.
1996), in which the Florida Supreme Court upheld a statute abrogating “[p]rinciples of common
law and equity as to assignment, lien subrogation, comparative negligence, assumption of risk,
and all other affirmative defenses normally available to a liable third party . . . to the extent
necessary to ensure full recovery by Medicaid from third-party resources. . . .” Id. at 1244-45
(quoting Medicaid Third-Party Liability Act, 1994 Fla. Laws ch. 251, §4). With the ordinary tort
law defenses cast aside by a marriage of legislative fiat and judicial acquiescence, the tobacco
companies predictably settled, first in Mississippi, Florida, Texas, and Minnesota, respectively,
and ultimately in a “global” settlement covering 46 states, 5 U.S. territories, and the District of
Columbia. For more on the “global” settlement, see Attorneys General, Tobacco Industry Finalize
$206 Billion Settlement, Health Law Rep. (BNA) No. 47, at 1885 (Dec. 3, 1998); for more on the
Minnesota settlement, see Tobacco Industry Settles Lawsuit with Minnesota, Blue Cross/Blue
Shield, Health Law Rep. (BNA) No. 20, at 779 (May 14, 1998); for more on the Texas settlement,
see Texas’ $15.3 Billion Settlement with Tobacco Companies is Largest Yet, Health Law Rep.
(BNA) No. 4, at 125 (Jan. 22, 1998); for more on the Florida settlement, see Tobacco Companies to
Pay $11.3 Billion to Settle Florida’s Reimbursement Suit, Health Law Rep. (BNA) No. 35 at D-10
(Aug. 28, 1997); and for more on the Mississippi settlement, see Attorney General Announces $3
Billion Deal with Tobacco Industry, Health Law Rep. (BNA) No. 28, at D-12 (July 10, 1997). But
see State ex rel. Miller v. Philip Morris Inc., 577 N.W.2d 401 (Iowa 1998) (finding the State has no
common law right to indemnity, that it failed to make a subrogation claim, and that it asserted
claims against tobacco companies as third-party injurers that failed under the remoteness
doctrine).
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The ordinary rule of liability required the plaintiff to show some defect in the
defendant’s product (usually in the warnings supplied), and allowed the
defendant some version of the assumption of risk defense--in this case the
continuous awareness of the individual smoker to the risks and hazards of
smoking--which had proven a powerful defense in these cases.
But in the Medicaid suits, the medical costs portion of the claim was
severed from the rest of the basic cause of action and brought by the states in
their roles as Medicaid suppliers. This move might have meant that all of these
medical claims were transferred by subrogation from individual claimants to
their health care providers. As a matter of fact, the original Medicaid contracts
with individual enrollees contained subrogation provisions that required the
transfer of the medical component of the claims to reimburse Medicaid for its
statutory expenditures. Under this subrogation regime, the assignments would
result in the formation of a quasi-class, subject of course to the individual
defenses, such as assumption of risk, that could be raised against each individual
smoker. Accordingly, Medicaid as subrogee would have been subjected to the
same merciless dissection of its patients’ personal habits as an individual
smoker/plaintiff (coupled with a convincing demonstration of the pervasive
public knowledge of the risks of smoking--knowledge that could not have
escaped the attention of even the most oblivious of smokers).
But the Medicaid claims were not treated as subrogation claims, and
instead becamse “independent” Medicaid claims, which achieved the same class71
like amalgamation without any formal assignment of claims or class actions.
And because Medicaid programs themselves are not smokers and in no way
contributed to their patients’ smoking, they faced no assumption of risk defense
or the like. This independent claim was often said to rest on the state’s public
duty to aid persons in need, but it is hardly clear why it should not be treated the
same way as any other subrogation claim. Indeed, if taken seriously, the
independent claim approach should be available to the insurer in every
automobile accident or product liability case, so that in each situation the only
thing that would need to be shown is some defect by the defendant that is said to
cause harm to the plaintiff. Yet the rule in question was only applied for the
benefit of Medicaid, and then only against the tobacco companies—the classic
case of ad hoc justice. The transformation of smokers’ claims into headless
claims for Medicaid reimbursement did exactly what no ordinary device of
71

In Agency for Health Care Admin., the statute at issue allowed the State to recover
damages for itself on behalf of a group of Medicaid recipients (functionally a class) who allegedly
suffered injuries from tobacco. While granting Florida the benefit of litigating for its own benefit
on behalf of a class, it also expressly abrogated the principles of assignment and subrogation and
the concomitant burden of overcoming affirmative defenses--including assumption of risk. 678
So.2d at 1244-45.
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assignment or amalgamation could achieve: it tilted the table in plaintiffs’
direction.
This same strategy—to avoid the affirmative defenses available in a
subrogation action— was also tried in cases brought by private health plans
72
(who are subject to the class action risk in MCO cases). The health plans
claimed that the systematic misrepresentation of the dangers of tobacco fooled
the health plans (and the plan enrollees) so that both were required to spend
more in treating tobacco-related illnesses than they would have if they had
received accurate information about the risks. One possible way to maintain
these claims is through subrogation parallel to that of the Medicaid cases, but
this strategy again created the danger that the individual defenses in each
individual case had to be litigated—a distinctive element that reduces the
number of common issues needed for class certification under Rule 23(b)(3). The
direct action for losses in their own stead avoided these difficulties, but only at
the cost of introducing other and greater distortions. The health plans in
question may not have known (although this is doubtful) of the risks associated
with smoking, but they did have accurate knowledge of the cost of treatment for
the populations that they insured. It is the pool characteristics generally that
determine the total costs of servicing the assumed risk, and the ultimate question
is whether the plans received a normal rate of return for their services as a group,
which in the competitive situation that existed surely seems to be the case. The
typical judicial response has denied the cause of action by appealing to a
notion—privity—that has surely lost its cachet in other contexts.
The
representations in question were made to smokers, not to the health plans. But
the doctrinal head is less important, generally speaking, than the result, which is
to recognize that the diffusion of information about the risks of smoking were
sufficiently well known to health plans that they cannot claim any unfair
surprise. Indeed the nebulous damages sought—”infrastructure” damages and
the lost benefits of educational programs (which cost before they can supply any
benefit)--speak to a cause of action composed of missing links. For our purpose
it indicates the same disturbing trend found in the Medicaid suits against the
tobacco companies--the development of novel theories of liability to circumvent
the critical proposition of class actions: amalgamation of claims should not lead
to an expansion of substantive rights.
Claim Diversification. The second major difficulty associated with the
use of class actions is perhaps more subtle but also profound: the loss of
72

See, e.g. Laborers Local 17 Health and Benefit Fund v. Philip Morris, Inc., 191 F.3d 229
(2d Cir. 1999). Subsequent to this decision Judge Weinstein opted for the subrogation approach,
with all its internal complexities, in National Asbestos Workers Medical Fund v. Philip Morris,
Inc., 74 F. Supp. 2d 213 (E.D.N.Y. 1999).
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diversification in the portfolio of adverse claims. The defendant that faces a large
number of individual suits does not face an all-or-nothing risk in actions of this
sort. Some cases will win, others lose; and some will settle on the strength of the
performance of the other cases. But once all claims are amalgamated, then all
claims stand or fall at once. The defendant often faces a risk of financial
ruination. Although finance theory may teach that the diversified shareholders
of public companies ought care little about such risk, CEOs and general counsels
may behave as though they are quite concerned about the possible demise of the
company, and may be driven to settlement of cases even if they have doubtful
merit. That result can be limited by dividing the large class into smaller ones:
certain years, certain states, certain products, or whatever. But even smaller
classes can be quite large, and the separations may only eliminate the lockstep
connections, but not the positive correlations.
To be sure, large groups of similar claims always present certain
nondiversifiable risks: precedent increases the correlation of outcomes, and at a
more concrete level the use of offensive collateral estoppel--which has achieved
some limited adoption--does the same thing by allowing the plaintiff in case B to
rely on the successful proof of some critical fact in case A. All of this is done in
the name of administrative cost control, but with real risks: offensive collateral
estoppel should not be allowed for the plaintiff who breaks through with success
73
after ten prior failures. The same attitude should carry over to class actions,
where broad certifications should be carefully watched to take this risk into
account.
B. Class Actions Against MCOs
With these preliminaries established, it is worthwhile to look more closely
at the class actions recently brought against MCOs on behalf of their plan
participants. We begin with the standard elements in the complaint. The
plaintiffs well understand that they must be able to show the predominance of
common issues over separate ones in order to obtain class certification. The first
maneuver is to disclaim any intention of “seeking to remedy claims of personal
injury, medical malpractice, and/or wrongful death.”74 Personal injury, medical
malpractice claims and wrongful death actions all involve particularized proof of
professional negligence that vary substantially from case to case, and no court
would ever certify a class with such enormous breadth and such ill-defined
contours. A further concern is that the class action attorneys do not wish to start
73

See, e.g., State Farm Fire & Cas. Co. v. Century Home Components, 550 P.2d 1185 (1976)
(rejecting offensive collateral estoppel where the defendant had succeeded in one previous
judgment and lost two others). For a classic treatment of this problem, see Brainerd Currie,
Mutuality of Collateral Estoppel: Limits on the Bernhard Doctrine, 9 Stan. L. Rev. 289 (1957).
74
See, e.g., Plaintiff’s Class Action Complaint at 6, ¶ 12, Williamson v. Prudential Insurance
Company of America, No. 2:99CV326 (S.D. Miss. filed Nov. 22, 1999).
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a class war with ordinary contingent fee lawyers who specialize in medical
malpractice.
A strategic retreat, however, does not a lawsuit make. What then do the
plaintiffs allege under their common law and RICO and ERISA hats? The
answer is a mix of fraud, nondisclosure and breach of contract and fiduciary
claims, all of which stem from the proposition that the health plans consistently
promise more than they are able to deliver to their full roster of private
subscribers. The number of subscribers tends to be quite large, and thus one
class action covers nearly four years, from November 1995 to August 1999, and
75
includes 6.6 million subscribers nationwide. Key allegations read as follows:
9. Contrary to Prudential’s false, misleading, and deceptive
misrepresentations, Prudential during the relevant time herein alleged
aggressively engaged in implementing covert systematic internal policies
and practices that resulted in the reduction of the quality of healthcare
services provided the plaintiff and the class, rather than maintaining and
improving the quality of their healthcare. These covert systematic internal
policies and practices were designed, inter alia, to discourage Prudential’s
healthcare providers from delivering medical services and intrude with
the medical judgment of Prudential healthcare providers by substituting
the judgment of claims reviewers—who had neither the appropriate
medical training nor the medical specialization to determine the medical
needs of Prudential enrollees—for the medical judgment of its physicians.
13. During the relevant herein alleged, the healthcare services
provided or made available to the plaintiff, the class, and the subclass
were worth far less than the health care services described in Prudential’s
advertising, marketing and member materials.76
In dealing with allegations of this sort, one District Court had little
difficulty in dismissing the class complaint by noting that “as a matter of law, it
is highly doubtful that advertising one’s commitment to ‘quality of care’ can
serve as the predicate for a fraud claim. Such general assertions as to quality are
puffery, and do not constitute a fraudulent inducement to membership in
defendants’ HMO plans, particularly where the complained-of cost containment
77
provisions are disclosed to prospective members.”

75

“The class consists of individuals who paid premiums or subscription payments, or on
whose behalf such payments had been made, and were or were named enrollees in any of
Prudential’s HMOs, PPOs, and POS plans at anytime during the class period from November 22,
1995 to August 6, 1999.” Id. at 3, ¶3. Excluded from the class are Medicare and Medicaid
members and any director, employee and officer of the defendant.
76
Id. at 5-6.
77
Maio v. Aetna Inc., No. CIV.A. 99-1969, 1999 WL 800315, at *2 (E.D. Pa. Sept. 29, 1999).
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This line of argument is as valid against a single action brought by one
MCO enrollee as by an entire class, and does not address the question of whether
class action status should be applied to this case if the substantive deficiencies in
the claim were somehow overcome. In this regard, it is useful to distinguish the
fraud from the breach of contract portions of the argument.
The basic law of class actions has long made it clear that suits for fraud are
possible, but fragile candidates for class action status: “although having some
common core, a fraud case may be unsuited for treatment as a class action if
there was material variation in the representations made or in the kinds or
78
degrees of reliance by the persons to whom they were addressed.”
Thus, the nature and source of the defendant’s representations in question
must be examined carefully. The plaintiffs duly allege that all the defendant’s
representations in question were “standardized and uniform” because they came
through the usual set of “marketing materials, including certificates of coverage,
member handbooks, member information, provider directories, and other
79
documents.” Unfortunately, this mode of pleading operates as a clear slight-ofhand. The complaint sets out no particulars whatsoever, itself a problem given
the somewhat puzzling Federal Rules requirement that fraud be pleaded “with
80
particularity.” But even if one did catalogue all the communications in these
various categories, that proof would provide no reason to believe that each
subscriber read and relied on the same set of materials. The case is not like a
typical securities case where the defendants have issued a single prospectus that
was read and relied upon by all. Different programs had different standardized
materials; and even two individuals who were part of the same plan need not
have read the same information at the same time. These standardized materials
are not, moreover, the only source of communications: oral communications with
physicians, nurses and plan personnel certainly help shape the responses of
different individuals. These deviations from standard norms were used to

78

Fed R. Civ. P. 23(b)(3) advisory committee’s note (1966). For cases that have denied class
certification in fraud/RICO contexts, see Martin v. Dahlberg, Inc., 156 F.R.D. 207 (N.D. Cal. 1994).
In Martin, the court analyzed alleged misrepresentations by manufacturers, retailers, franchisees
and hearing consultants on the sale of hearing aids and found “[t]he diversity of sources of
information, the diversity of messages generated by those interested in selling Dahlberg products,
and the potential for differing reliance on varied information weigh strongly against class
adjudication of the critical issue of reliance.” Id. at 215. See also, Rodriguez v McKinney, 156
F.R.D. 112 (E.D. Pa. 1994) (rejecting fraud/RICO cases for insufficient benefits given to students
without high school diplomas who attended trade schools, noting the difficulties on the reliance
question, both from affirmative misrepresentations and nondisclosures).
79
Plaintiff’s Class Action Complaint at 4, ¶¶4-5.
80
Fed R. Civ. P. 9(b) states: “In all averments of fraud or mistake, the circumstances
constituting fraud or mistake shall be stated with particularity.”
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undercut the adequacy of written warnings in drug and vaccine cases, and
those differences should not be ignored here. Add to these structural features
the observation that many of the negotiations for plan membership were made
by informed intermediaries (e.g. employers, unions, churches, fraternal
organizations) and the like, and it seems as though the issue of what counts as
fraud, and what counts as reliance will differ substantially. One possible
response is to break down the single class of 6.6 million into subclasses, so that
all persons who were enrolled in HMOs, for example, could be treated separately
from those who were enrolled in PPOs and POS plans. But even this move
conceals the differences that might arise when individuals join plans at different
times, or are subject to somewhat different disclosure requirements as mandated
under different systems of state law.
Another way to skirt these difficulties is to hold the plans responsible for
what they did not disclose rather than what they said. The argument here is that
silence is uniform across different audiences even if speech is not. But the
counterarguments seem more cogent here as well. Initially, the content of the
required disclosures depends in part on the types of coverage being offered and
in part on the nature of the target audience, and these will vary from case to case.
In addition, the impact of the nondisclosures will at a minimum depend on both
what else has been said, and on what statutory obligations to disclose can be
found under local law. In the end, therefore, the same class action fate ought to
await the nondisclosure claims as the misrepresentation claims. They do not
present the single decisive moment that allows for class amalgamation.
The next question is whether the outcome differs when the issue switches
from misrepresentation to breach of contract, as suggested in paragraph 13 set
out above. The answer is clearly “no”: to figure out whether individuals have
been short-changed in the delivery of health care services, someone has to decide
just how much health care was given to what individuals. None of the actions
contemplate such analysis with respect to individual class members. The theory
has to be that on average all individuals received care inferior to what was
promised them at the outset so that relief comes in one of two forms: either a
comprehensive refund to every class member, or some form of prospective
structural relief for the benefit of all class members. These forms of relief raise
serious questions, both for the question of class certification and for the
soundness of the underlying complaint.
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The implications of the nonperformance allegations from paragraph 13 of
the basic class action complaint are made clearer when those allegations are
juxtaposed against the rhetoric that accompanies it: “Aetna is one of the most
reprehensible companies in this respect. . . . It’s been fairly aggressive about
82
pursuing a policy of cost-containment with its doctors.” These statements leave
it unclear whether the claim for loss of the benefit of bargain works in the
interests of any, let alone all members of the putative class. It is easy enough to
assume that refunds to all class members might be desirable for past periods, at
least if they do not cripple the ability of the firm to operate as before in future
periods. But it is far from clear that the class members share a common interest
in the nature and quality of services that they wish to receive from MCO
organizations. The plaintiffs in effect claim that there is a particular standard of
care is required from the defendant across a range of its health plans, but the
complaint offers no evidence whatsoever that the standard of care that it
stipulates as desirable is in fact optimal for all members of the group given their
different financial constraints and consumer preferences. It could well be that
the class action would, if allowed to go forward, set the standard of care such
that in the mandated equilibrium large numbers of potential enrollees drop out,
which in turn could increase the costs on the shrunken group that now remains.
The problem of organizing a class action becomes more acute when it is noted
that some members of the class may suffer from preexisting conditions, with the
special problems that it entails, while others do not. The thought that one should
supply uniform care levels to all participants of all plans makes none of the
quality differentiation by income and taste that is characteristic of markets. This
observation should be more than sufficient for the conclusion that the class action
is an inappropriate vehicle for imposing either minimum or uniform standards
on the health care industry.
Likewise, the hallmark of managed care is cost-containment, and its
proliferation suggests that many consumers desire it ex ante, even if it is reviled
ex post by the fraction of individuals to whom it is applied. To take the position
that all such efforts are misguided, or even that cost containment must be done in
certain judicially prescribed ways, is not a proper fix for the MCO, but its death
knell. There can be all sorts of mechanisms for controlling costs: the trade-off
between increased (or earlier) access and cost is hardly straightforward. The one
wrong approach would be to suppose that a trial court judge knows best what
mechanism to decree.
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Finally, some note must be made of the relationship between these suits
alleging lost benefits in quality of care and the availability of individual
malpractice actions. As noted earlier, the class action complaint carves out from
consideration all malpractice actions and remits them to the tort system. But the
consequence of supplying insufficient medical benefits to patients in relation to
what was promised may often be actionable malpractice as well. If a court
chooses to order a refund under these umbrella contract claims plaintiffs may in
effect receive double compensation for at least those mistakes in treatment that
are caught by the medical malpractice system
As a concluding caution, while we oppose many of the substantive
provisions of the various so-called patients’ bills of rights, we think that the
merits of managed care regulation are better resolved in the legislative arena.
Regulatory proposals have been the source of contentious debates in Congress
and the states, and it is dangerous to assume that the democratic process has in
some sense failed because these proposals have not always been enacted into
law. Both sides have a fair crack at success, and each is armed with ample funds
to pursue its object in the political arena. A political defeat should not be
regarded as a miscarriage of justice to be remedied by other means, often judicial
in character. Rather, the central question should be the level at which legislative
reforms, if any, should be introduced. If single, comprehensive national reforms
are required, then federal legislation becomes the appropriate vehicle of reform.
If matters are properly resolved differently by different states, then statewide
legislation seems to be appropriate. Our instinct is that a period of experimental
reform at the state level certainly makes sense before any blanket policy is
mandated nationally. But in any event, everyone should have some rights of
participation on matters of this importance, not just the parties to a particular
lawsuit. The class action is simply not a suitable vehicle for any system-wide
reform of the health care delivery system.
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